Uterine Artery Embolization Successfully Controls Postpartum Hemorrhage
By Lori Solomon HealthDay Reporter
MONDAY, March 25, 2024 -- Uterine artery embolization (UAE) has a high rate of success in controlling postpartum hemorrhage (PPH), according to a study presented at the annual meeting of the Society of Interventional Radiology, held from March 23 to 28 in Salt Lake City.
Younes Jahangiri, M.D., from Corewell Health West Michigan in Grand Rapids, and colleagues evaluated short- and long-term outcomes of UAE for treatment of uncontrolled PPH among 66 patients treated from January 2014 to December 2022.
The researchers found that the median time between PPH onset and UAE was four hours and 18 minutes (range, 11 minutes to 15 days, 23 hours, and 49 minutes). Median pre-embolization blood loss was 2,760 mL, with pre-embolization transfusion administered in 54 of 66 patients (82 percent). Embolization had a median duration of 67 minutes (range, 31 to 222 minutes). A lower international normalized ratio and higher fibrinogen levels prior to embolization were associated with better hemorrhage control. No deaths occurred during or after embolization, but four patients with unsuccessful hemorrhage control subsequently underwent total abdominal hysterectomy. African-American women and those with higher pre-embolization blood loss had a higher risk for postembolization syndrome, including fever or abdominal pain, which occurred in 36 percent of cases.
"Based on these findings, we would encourage obstetricians to involve interventional radiologists early, to be ready to perform UAE if more conservative approaches are not managing postpartum hemorrhage," senior author James Morrison, M.D., from the Michigan State University College of Human Medicine in Grand Rapids, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns...
Maternal Distress Tied to Changes in Brain Growth of Offspring
FRIDAY, June 21, 2024 -- Regional neonatal brain volumes are associated with elevated maternal psychological distress, according to a study published online June 20 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.